Literature DB >> 33662022

Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.

Phunchai Charatcharoenwitthaya1, Kamonthip Sukonrut1, Pornpim Korpraphong2, Ananya Pongpaibul3, Pairash Saiviroonporn2.   

Abstract

BACKGROUND: Accurate noninvasive methods for the assessment of liver fibrosis are urgently needed. This prospective study evaluated the diagnostic accuracy of diffusion-weighted magnetic resonance imaging (DWI) for the staging of liver fibrosis and proposed a diagnostic algorithm using DWI to identify cirrhosis in patients with chronic viral hepatitis.
METHODS: One hundred twenty-one treatment-naïve patients with chronic hepatitis B or C were evaluated with DWI followed by liver biopsy on the same day. Breath-hold single-shot echo-planar DWI was performed to measure the apparent diffusion coefficient (ADC) of the liver and spleen. Normalized liver ADC was calculated as the ratio of liver ADC to spleen ADC.
RESULTS: There was an inverse correlation between fibrosis stage and normalized liver ADC (p<0.05). For the prediction of fibrosis stage ≥2, stage ≥3, and cirrhosis, the area under the receiver-operating curve of normalized liver ADC was 0.603, 0.704, and 0.847, respectively. The normalized liver ADC value ≤1.02×10-3 mm2/s had 88% sensitivity, 81% specificity, 25% positive predictive value (PPV), and 99% negative predictive value (NPV) for the diagnosis of cirrhosis. Using a sequential approach with the Fibrosis-4 index followed by DWI, normalized liver ADC ≤1.02×10-3 mm2/s in patients with Fibrosis-4 >3.25 yielded an 80% PPV for cirrhosis, and a 100% NPV to exclude cirrhosis in patients with Fibrosis-4 between 1.45 and 3.25. Only 15.7% of patients would require a liver biopsy. This sequential strategy can reduce DWI examinations by 53.7%.
CONCLUSION: Normalized liver ADC measurement on DWI is an accurate and noninvasive tool for the diagnosis of cirrhosis in patients with chronic viral hepatitis.

Entities:  

Year:  2021        PMID: 33662022      PMCID: PMC7932524          DOI: 10.1371/journal.pone.0248024

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  32 in total

1.  Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.

Authors:  Richard K G Do; Hersh Chandarana; Hersh Chandanara; Ely Felker; Cristina H Hajdu; James S Babb; Danny Kim; Bachir Taouli
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

2.  Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure.

Authors:  Denis Le Bihan
Journal:  Radiology       Date:  2013-08       Impact factor: 11.105

Review 3.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

4.  EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.

Authors: 
Journal:  J Hepatol       Date:  2015-04-21       Impact factor: 25.083

5.  Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience.

Authors:  Jignesh Patel; Eric E Sigmund; Henry Rusinek; Marcel Oei; James S Babb; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2010-03       Impact factor: 4.813

6.  Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis.

Authors:  Susanne Bonekamp; Michael S Torbenson; Ihab R Kamel
Journal:  J Clin Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 3.062

7.  Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study.

Authors:  Alain Luciani; Alexandre Vignaud; Madeleine Cavet; Jeanne Tran Van Nhieu; Ariane Mallat; Lucile Ruel; Alexis Laurent; Jean-François Deux; Pierre Brugieres; Alain Rahmouni
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

Review 8.  Diffusion-weighted MRI for the assessment of liver fibrosis: principles and applications.

Authors:  Stefano Palmucci; Giuseppina Cappello; Giancarlo Attinà; Giovanni Fuccio Sanzà; Pietro Valerio Foti; Giovanni Carlo Ettorre; Pietro Milone
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

9.  Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017.

Authors:  Shanley Smith; Hande Harmanci; Yvan Hutin; Sarah Hess; Marc Bulterys; Raquel Peck; Bharat Rewari; Antons Mozalevskis; Messeret Shibeshi; Mutale Mumba; Linh-Vi Le; Naoko Ishikawa; Désiré Nolna; Leandro Sereno; Charles Gore; David J Goldberg; Sharon Hutchinson
Journal:  JHEP Rep       Date:  2019-05-10

10.  Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

Authors: 
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

View more
  1 in total

Review 1.  Magnetic Resonance Imaging of Liver Fibrosis, Fat, and Iron.

Authors:  Christopher L Welle; Michael C Olson; Scott B Reeder; Sudhakar K Venkatesh
Journal:  Radiol Clin North Am       Date:  2022-07-15       Impact factor: 1.947

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.